DISCREET Drug Coating
Hybrid Stent Design
DES Clinical Trials
Board of Directors
Medical Advisory Board
In the News
Less is More
A new approach to coronary stenting, Svelte IDS and RX technologies
reduce the steps, time and cost of procedures while enhancing patient outcomes.
Downsize Catheters, Facilitate TRI
The SLENDER IDS stent-on-a-wire attains profiles HALF those of conventional DES,
reducing catheter size and facilitating transradial intervention.
Direct Stent with Confidence
The DIRECT RX rapid-exchange DES provides low profiles and
specialized balloon technology to direct stent more lesions safely.
Simplify the Complex
Svelte technologies downsize catheters and streamline PCI, even in challenging cases.
Learn How Svelte Technologies Benefit: